Julia Wang, CFO of BeiGene Ltd, sold 899 shares at $155.66 each, owning 432,731 shares. The biotech company focuses on cancer treatments globally. Wang's recent sale raises interest due to insider behavior and the stock's valuation metrics.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing